Immunovaccine develops cancer immunotherapies and infectious disease vaccines based on a patented formulation providing controlled and prolonged exposure of antigens and adjuvant to the immune system : DepoVax.
Immunovaccine develops cancer immunotherapies and infectious disease vaccines based on a patented formulation providing controlled and prolonged exposure of antigens and adjuvant to the immune system : DepoVax.
Innate Immunotherapeutics is a medical biotechnology company designing and producing a unique immunomodulator microparticle technology. This innovative technology is able to induce the human immune system to fight certain types of cancer or infections, but also to modulate certain immune mechanisms implicated in autoimmune diseases (like the ones implicated in Multiple Sclerosis).